Catheters News and Research

RSS

FDA approves St. Jude Medical's EnSite Velocity Cardiac Mapping System

St. Jude Medical, Inc. (NYSE: STJ) today announced U.S. Food and Drug Administration (FDA) clearance and U.S. launch of its EnSite Velocity™ Cardiac Mapping System. This new system has been designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.

14 Sep 2009

Careless practices takes a heavy toll on American lives, says President of SAVE THE PATIENT

Is anyone listening? As this debate rages on about medical reform, patient safety organizations, those of us at the front each and every day, we do not hear about what is happening to the people from the senseless health care devastation throughout our country right now.

11 Sep 2009

Mid-Atlantic region’s first laparoscopic gastric banding surgery performed at AEHN

Albert Einstein Healthcare Network (AEHN) announced today that its chief bariatric surgeon successfully performed the Mid-Atlantic region’s first laparoscopic gastric banding surgery, which is performed through a single incision in a patient’s umbilicus (or belly button), ultimately resulting in the potential for no visible scar.

8 Sep 2009

Strata brands of Foley catheters launched by Rochester Medical Corporation

Rochester Medical Corporation (Nasdaq: ROCM) today announced the introduction of its Strata brands of Foley catheters. This new Foley product line features proprietary comfort layered technology. The company's StrataSI(TM) catheter is all-silicone, while the StrataNF(TM) version includes a nitrofurazone anti-infective matrix within the silicone.

4 Sep 2009

AVA issues guidelines for disinfecting IV catheters

How to meet new infection-control guidelines from the Joint Commission and the SHEA/IDSA Compendium will be the focus of a panel discussion at the upcoming annual meeting of the Association for Vascular Access (AVA).

3 Sep 2009

Atrial fibrillation ablation - one of the fastest growing cardiology techniques

Atrial fibrillation ablation is one of the fastest growing techniques in cardiology and due to the very high number of patients that might be candidates to this procedure, a significant number of resources will have to be devoted to it to be able to treat them in the following years.

1 Sep 2009

FDA approves Hospira's six new vial presentations of heparin

Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's applications for six new presentations of therapeutic heparin in single- and multiple-dose vials.

1 Sep 2009

Stony Brook University Hospital and EPA sign historic green partnership

Stony Brook University Hospital in Stony Brook, N.Y. is not just the only university-based hospital on Long Island, it is the first hospital in the nation to pledge to reduce its environmental impact through a comprehensive agreement with the U.S. Environmental Protection Agency (EPA).

26 Aug 2009

Medline Industries' Foley catheter management system helps minimize CAUTI risk

In an effort to help clinicians reduce the risk of catheter-associated urinary tract infections (CAUTI), Medline Industries, Inc. today launched a ground-breaking Foley catheter management system featuring a reengineered catheter tray coupled with an evidence-based clinical education program.

25 Aug 2009

Mount Sinai Medical Center physicians pioneer a non-surgical procedure for treating LAA

Physicians at The Mount Sinai Medical Center were the first in the country to perform a non-surgical procedure using sutures to tie off a left atrial appendage (LAA), which is the source of blood clots leading to stroke in patients with atrial fibrillation (AFib). AFib is the most common sustained heart-rhythm disorder in the United States.

24 Aug 2009

Inovio Biomedical records $2.9 million revenues in the six months ended June 30, 2009

Inovio Biomedical Corporation (NYSE AMEX: INO) (“Inovio”) today reported financial results for the three and six months ended June 30, 2009. Total revenue of $2.5 million and $2.9 million for the three and six months ended June 30, 2009, compared to $663,000 and $1.3 million for the three and six months ended June 30, 2008, respectively.

20 Aug 2009

Cardiovascular Systems' revenues in fourth-quarter of 2009 increases to $15.7 million

Cardiovascular Systems, Inc. (CSI), a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fourth quarter and fiscal year ended June 30, 2009.

19 Aug 2009

New method for neonatal icus reduces infection and lung distress in preemies

A new method for improving quality of care can reduce hospital-acquired infections and chronic respiratory distress with oxygen dependency in premature infants in neonatal ICUs, according to a new study in CMAJ (Canadian Medical Association Journal).

11 Aug 2009

FDA approves Hologic's permanent contraception system

Hologic, Inc.today announced the U.S. Food and Drug Administration (FDA) has approved the Company's premarket approval (PMA) application for the Adiana permanent contraception system.

From Hologic, Inc. 7 Jul 2009

New peripherally inserted central catheter mimics nature

A novel coating being used on a new peripherally inserted central catheter (PICC) from r4 Vascular mimics the cell layer found on natural tissue surfaces.

30 Jun 2009

Honey more effective than antibiotics

In the first study of its kind University of Sydney researchers have found proof that some honeys can be more effective than antibiotics in treating surface wounds and infections.

17 Jun 2009

Minimally invasive treatment of brain tumors on the horizon

Duke University engineers have taken a first step toward a minimally invasive treatment of brain tumors by combining chemotherapy with heat administered from the end of a catheter.

17 Jun 2009

Plant microbe shares features with drug-resistant pathogen - implications for biotech

An international team of scientists has discovered extensive similarities between a strain of bacteria commonly associated with plants and one increasingly linked to opportunistic infections in hospital patients. The findings suggest caution in the use of the plant-associated strain for a range of biotech applications. The genetic analysis was conducted in part at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory, and will be published in the July 2009 issue of Nature Reviews Microbiology, now available online.

16 Jun 2009

Researchers discover six new genome sequences and fundamental insights to the Candida fungus family

An international research collaboration coordinated by UCD researchers and involving scientists at 21 institutes including the genome sequencing centres in the Wellcome Trust Sanger Institute, UK and the Broad Institute at MIT and Harvard, USA have defined six new genome sequences in the Candida fungus family and identified genetic differences in species that cause disease.

25 May 2009

Chemical found in medical devices impairs heart function

Researchers at the Johns Hopkins University School of Medicine have found that a chemical commonly used in the production of such medical plastic devices as intravenous (IV) bags and catheters can impair heart function in rats.

3 May 2009